12 Health Care Stocks Moving In Wednesday's After-Market Session

Loading...
Loading...

Gainers

  • Sharps Technology STSS stock increased by 56.5% to $0.4 during Wednesday's after-market session. The market value of their outstanding shares is at $6.3 million.
  • Geovax Labs GOVX shares moved upwards by 21.71% to $2.27. The market value of their outstanding shares is at $5.2 million.
  • NexImmune NEXI stock increased by 9.52% to $3.45. The company's market cap stands at $4.7 million. As per the news, the Q1 earnings report came out 2 days ago.
  • Cognition Therapeutics CGTX stock rose 8.04% to $2.83. The market value of their outstanding shares is at $113.3 million.
  • Clearside Biomedical CLSD shares rose 7.39% to $1.45. The market value of their outstanding shares is at $108.3 million.
  • Unicycive Therapeutics UNCY stock moved upwards by 6.46% to $1.07. The market value of their outstanding shares is at $40.2 million.

Losers

  • TransCode Therapeutics RNAZ shares decreased by 13.2% to $1.25 during Wednesday's after-market session. The market value of their outstanding shares is at $8.2 million.
  • Cytokinetics CYTK stock declined by 11.54% to $52.4. The company's market cap stands at $5.4 billion.
  • NovaBay Pharmaceuticals NBY stock fell 7.3% to $0.13. The market value of their outstanding shares is at $4.9 million.
  • Qilian Intl Hldg Gr QLI shares declined by 6.44% to $0.58. The market value of their outstanding shares is at $20.7 million.
  • SenesTech SNES stock declined by 6.24% to $0.75. The market value of their outstanding shares is at $3.8 million.
  • Cingulate CING shares fell 6.23% to $0.76. The company's market cap stands at $4.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...